Key result
Sonazoid-enhanced CDUS improves soft tissue tumor diagnostic sensitivity to ~87% versus unenhanced imaging.
Why the study?
Contrast-enhanced color Doppler ultrasonography using Sonazoid has been newly available and its ability to differentiate benign from malignant soft tissue tumors needed evaluation.
Does contrast-enhanced color Doppler ultrasonography with Sonazoid improve diagnostic accuracy for differentiating benign and malignant soft tissue tumors compared to unenhanced CDUS?
Observational (n=180)
No
Does contrast-enhanced color Doppler ultrasonography with Sonazoid improve diagnostic accuracy for differentiating benign and malignant soft tissue tumors compared to unenhanced CDUS?
Contrast-enhanced color Doppler ultrasonography with Sonazoid improves sensitivity and overall accuracy for detecting malignant potential in soft tissue tumors compared to unenhanced imaging.
Answers are grounded in this paper and cite their sources.
May support noninvasive soft tissue tumor differentiation; hypothesis-generating and requires prospective validation before practice change.
Resolution of ultrasonography (US) has undergone marked development. Additionally, a new-generation contrast medium (Sonazoid) used for US is newly available. Contrast-enhanced US has been widely used for evaluating several types of cancer. In the present study, we evaluated the ability of color Doppler US (CDUS) and Sonazoid to differentiate between benign and malignant soft tissue tumors. A total of 180 patients (87 male, 93 female) were enrolled in the present study. The patient ages ranged from 1 to 91 years (mean 58.1±20.0 years). The maximum size, depth, tumor margins, shape, echogenicity and textural pattern were measured on gray-scale images. CDUS was used to evaluate the intratumoral blood flow with and without Sonazoid. Peak systolic flow velocity (Vp), mean flow velocity (Vm), resistivity index (RI) and pulsatility index (PI) of each detected intratumoral artery were automatically calculated with power Doppler US (PDUS). The present study included 118 benign and 62 malignant tumors. Statistical significances were found in size, depth, tumor margin and textural pattern but not in shape or echogenicity on gray-scale images. Before Sonazoid injection, CDUS findings showed 55% sensitivity, 77% specificity and 69% accuracy, whereas contrast-enhanced CDUS showed 87% sensitivity, 68% specificity and 74% accuracy. There were no statistically significant differences between malignant and benign tumors regarding the mean Vp, Vm, RI and PI values determined on PDUS. In conclusion, contrast-enhanced CDUS proved to be a reliable diagnostic tool for detecting malignant potential in soft tissue tumors.
No takes yet. Share an insight, caveat, or question.
Oebisu et al. (2014) conducted an observational in Soft tissue tumors (n=180). Contrast-enhanced color Doppler ultrasonography (Sonazoid) vs. Unenhanced color Doppler ultrasonography was evaluated on Diagnostic accuracy for differentiating benign and malignant soft tissue tumors. Contrast-enhanced color Doppler ultrasonography using Sonazoid increased diagnostic sensitivity to 87% and accuracy to 74% compared to 55% and 69% with unenhanced imaging for differentiating soft tissue tumors.
Synapse has enriched 10 related papers. Consider them for comparative context: